# Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer

> **NCT01325142** · — · COMPLETED · sponsor: **University of Michigan** · enrollment: 271 (actual)

## Conditions studied

- Bone Diseases
- Metastases
- Osteonecrosis
- Bisphosphonate-Associated Osteonecrosis of the Jaw

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01325142
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-08
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 271 (ACTUAL)
- **Last updated:** 2014-12-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01325142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01325142, "Genetic Risk of Osteonecrosis of the Jaw (ONJ) in Patients With Metastatic Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01325142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*